Literature DB >> 28706073

Mouse models of acute and chronic hepacivirus infection.

Eva Billerbeck1, Raphael Wolfisberg2, Ulrik Fahnøe2, Jing W Xiao1, Corrine Quirk1, Joseph M Luna1, John M Cullen3, Alex S Hartlage4, Luis Chiriboga5, Kalpana Ghoshal6, W Ian Lipkin7, Jens Bukh2, Troels K H Scheel1,2, Amit Kapoor4, Charles M Rice8.   

Abstract

An estimated 71 million people worldwide are infected with hepatitis C virus (HCV). The lack of small-animal models has impeded studies of antiviral immune mechanisms. Here we show that an HCV-related hepacivirus discovered in Norway rats can establish high-titer hepatotropic infections in laboratory mice with immunological features resembling those seen in human viral hepatitis. Whereas immune-compromised mice developed persistent infection, immune-competent mice cleared the virus within 3 to 5 weeks. Acute clearance was T cell dependent and associated with liver injury. Transient depletion of CD4+ T cells before infection resulted in chronic infection, characterized by high levels of intrahepatic regulatory T cells and expression of inhibitory molecules on intrahepatic CD8+ T cells. Natural killer cells controlled early infection but were not essential for viral clearance. This model may provide mechanistic insights into hepatic antiviral immunity, a prerequisite for the development of HCV vaccines.
Copyright © 2017, American Association for the Advancement of Science.

Entities:  

Mesh:

Year:  2017        PMID: 28706073      PMCID: PMC5654634          DOI: 10.1126/science.aal1962

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  22 in total

Review 1.  Immune Memory and Exhaustion: Clinically Relevant Lessons from the LCMV Model.

Authors:  D Zehn; E J Wherry
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

2.  Liver-resident NK cells confer adaptive immunity in skin-contact inflammation.

Authors:  Hui Peng; Xiaojun Jiang; Yonglin Chen; Dorothy K Sojka; Haiming Wei; Xiang Gao; Rui Sun; Wayne M Yokoyama; Zhigang Tian
Journal:  J Clin Invest       Date:  2013-03-25       Impact factor: 14.808

Review 3.  The ins and outs of hepatitis C virus entry and assembly.

Authors:  Brett D Lindenbach; Charles M Rice
Journal:  Nat Rev Microbiol       Date:  2013-09-10       Impact factor: 60.633

4.  Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

Authors:  Shu-Hao Hsu; Bo Wang; Janaiah Kota; Jianhua Yu; Stefan Costinean; Huban Kutay; Lianbo Yu; Shoumei Bai; Krista La Perle; Raghu R Chivukula; Hsiaoyin Mao; Min Wei; K Reed Clark; Jerry R Mendell; Michael A Caligiuri; Samson T Jacob; Joshua T Mendell; Kalpana Ghoshal
Journal:  J Clin Invest       Date:  2012-07-23       Impact factor: 14.808

Review 5.  Surveying the global virome: identification and characterization of HCV-related animal hepaciviruses.

Authors:  Troels K H Scheel; Peter Simmonds; Amit Kapoor
Journal:  Antiviral Res       Date:  2014-12-26       Impact factor: 5.970

Review 6.  Hepatitis C virus: why do we need a vaccine to prevent a curable persistent infection?

Authors:  Christopher M Walker; Arash Grakoui
Journal:  Curr Opin Immunol       Date:  2015-08-01       Impact factor: 7.486

Review 7.  Animal models for hepatitis C.

Authors:  Eva Billerbeck; Ype de Jong; Marcus Dorner; Cynthia de la Fuente; Alexander Ploss
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

8.  Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection.

Authors:  Michael A Paley; Daniela C Kroy; Pamela M Odorizzi; Jonathan B Johnnidis; Douglas V Dolfi; Burton E Barnett; Elizabeth K Bikoff; Elizabeth J Robertson; Georg M Lauer; Steven L Reiner; E John Wherry
Journal:  Science       Date:  2012-11-30       Impact factor: 47.728

9.  ViVaMBC: estimating viral sequence variation in complex populations from illumina deep-sequencing data using model-based clustering.

Authors:  Bie Verbist; Lieven Clement; Joke Reumers; Kim Thys; Alexander Vapirev; Willem Talloen; Yves Wetzels; Joris Meys; Jeroen Aerssens; Luc Bijnens; Olivier Thas
Journal:  BMC Bioinformatics       Date:  2015-02-22       Impact factor: 3.169

10.  Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection.

Authors:  Shawn D Blackburn; Haina Shin; W Nicholas Haining; Tao Zou; Creg J Workman; Antonio Polley; Michael R Betts; Gordon J Freeman; Dario A A Vignali; E John Wherry
Journal:  Nat Immunol       Date:  2008-11-30       Impact factor: 25.606

View more
  44 in total

1.  A hepatitis B virus causes chronic infections in equids worldwide.

Authors:  Andrea Rasche; Felix Lehmann; Nora Goldmann; Michael Nagel; Andres Moreira-Soto; Daniel Nobach; Ianei de Oliveira Carneiro; Nikolaus Osterrieder; Alex D Greenwood; Eike Steinmann; Alexander N Lukashev; Gerhard Schuler; Dieter Glebe; Jan Felix Drexler
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-30       Impact factor: 11.205

2.  Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells.

Authors:  Raphael Wolfisberg; Kenn Holmbeck; Louise Nielsen; Amit Kapoor; Charles M Rice; Jens Bukh; Troels K H Scheel
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

Review 3.  Can infections trigger alpha-synucleinopathies?

Authors:  Christopher T Tulisiak; Gabriela Mercado; Wouter Peelaerts; Lena Brundin; Patrik Brundin
Journal:  Prog Mol Biol Transl Sci       Date:  2019-07-03       Impact factor: 3.622

4.  Rodent hepatitis C model.

Authors:  Laurie A Dempsey
Journal:  Nat Immunol       Date:  2017-08-22       Impact factor: 25.606

5.  Of mice, rats, and men: Small animal model of hepatitis C virus infection.

Authors:  Arash Grakoui; Christopher M Walker
Journal:  Hepatology       Date:  2018-05-09       Impact factor: 17.425

Review 6.  Natural killer cells in liver diseases.

Authors:  Meijuan Zheng; Haoyu Sun; Zhigang Tian
Journal:  Front Med       Date:  2018-04-19       Impact factor: 4.592

Review 7.  Murine Models of Hepatitis A Virus Infection.

Authors:  Asuka Hirai-Yuki; Jason K Whitmire; Michael Joyce; D Lorne Tyrrell; Stanley M Lemon
Journal:  Cold Spring Harb Perspect Med       Date:  2019-01-02       Impact factor: 6.915

8.  A mouse model for hepatitis C virus infection: are we there yet?

Authors:  Cordelia Manickam; R Keith Reeves
Journal:  Ann Infect       Date:  2017-11-30

9.  Viral persistence, liver disease, and host response in a hepatitis C-like virus rat model.

Authors:  Sheetal Trivedi; Satyapramod Murthy; Himanshu Sharma; Alex S Hartlage; Arvind Kumar; Sashi V Gadi; Peter Simmonds; Lokendra V Chauhan; Troels K H Scheel; Eva Billerbeck; Peter D Burbelo; Charles M Rice; W Ian Lipkin; Kurt Vandegrift; John M Cullen; Amit Kapoor
Journal:  Hepatology       Date:  2018-05-21       Impact factor: 17.425

10.  Single-Dose Vaccination with a Hepatotropic Adeno-associated Virus Efficiently Localizes T Cell Immunity in the Liver with the Potential To Confer Rapid Protection against Hepatitis C Virus.

Authors:  Zelalem A Mekonnen; Branka Grubor-Bauk; Kieran English; Preston Leung; Makutiro G Masavuli; Ashish C Shrestha; Patrick Bertolino; David G Bowen; Andrew R Lloyd; Eric J Gowans; Danushka K Wijesundara
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.